Reginald L. Hardy - 23 Jul 2021 Form 4 Insider Report for Brickell Biotech, Inc.

Role
CHAIRMAN OF THE BOARD, Director
Signature
/s/ Christine G. Long, Attorney-in-Fact for Reginald L. Hardy (power of attorney previously filed)
Issuer symbol
N/A
Transactions as of
23 Jul 2021
Net transactions value
+$133,650
Form type
4
Filing time
27 Jul 2021, 16:43:06 UTC
Previous filing
14 Jun 2021
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase $66,230 +100,000 +40% $0.6623 348,411 23 Jul 2021 Direct F1
transaction FRTX Common Stock Purchase $67,420 +100,000 +29% $0.6742 448,411 26 Jul 2021 Direct F2
holding FRTX Common Stock 9,261 23 Jul 2021 By Spouse
holding FRTX Common Stock 21,826 23 Jul 2021 By Spouse (spouse jointly owns with other Individual)
holding FRTX Common Stock 17,260 23 Jul 2021 By Spouse as Trustee
holding FRTX Common Stock 266,447 23 Jul 2021 By Self as General Partner
holding FRTX Common Stock 17,260 23 Jul 2021 By Self as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.66 to $0.6720 per share, resulting in a weighted average purchase price of $0.6623. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
F2 Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.671 to $0.678 per share, resulting in a weighted average purchase price of $0.6742. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.